Ledger.Open graph →
SEC Form D · Amendment · filed June 2, 2022

Predictive Oncology Inc

Offering
$2.3M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EAGAN, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Bob M. Myers · Eagan, MNExecGregory E. St. Clair · Eagan, MNDirectorChuck M. Nuzum · Eagan, MNDirectorNancy E. Chung-Welch · Eagan, MNDirectorChristina E. Jenkins · Eagan, MNDirectorRaymond E. Vennare · Eagan, MNDirectorDaniel E. Handley · Eagan, MNDirectorChristopher Ritter · Chicago, ILDirectorChris C. Kemp · Alameda, CADirectorMartin Attiq · Alameda, CAExecJames Paul · Chicago, ILDirectorLisa E. Nelson · Alameda, CADirectorMichael E. Lehman · Alameda, CADirectorAxel E. Martinez · Alameda, CADirectorJ M. Engle · Eagan, MNExec · DirectorMichael E. Pfau · Santa Barbara, CADirectorTaylor N. Beaupin · MANHATTAN BEACH, CADirectorRon Levy · Malibu, CADirectorOliver Nordlinger · Beverly Hills, CAExecJared Stein · Beverly Hills, CADirectorAndrew Perlman · San Francisco, CADirectorDhanurjay Patil · San Francisco, CADirectorJ M. Engle · Eagan, MNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗